Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
- 11 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 600 (7889), 523-529
- https://doi.org/10.1038/s41586-021-04085-y
Abstract
The emergence of SARS-CoV-2 variants with mutations in major neutralizing antibody-binding sites can affect humoral immunity induced by infection or vaccination1–6. We analysed the development of anti-SARS-CoV-2 antibody and T cell responses in previously infected (recovered) or uninfected (naive) individuals that received mRNA vaccines to SARS-CoV-2. While previously infected individuals sustained higher antibody titres than uninfected individuals post-vaccination, the latter reached comparable levels of neutralization responses to the ancestral strain after the second vaccine dose. T cell activation markers measured upon spike or nucleocapsid peptide in vitro stimulation showed a progressive increase after vaccination. Comprehensive analysis of plasma neutralization using 16 authentic isolates of distinct locally circulating SARS-CoV-2 variants revealed a range of reduction in the neutralization capacity associated with specific mutations in the spike gene: lineages with E484K and N501Y/T (e.g., B.1.351 and P.1) had the greatest reduction, followed by lineages with L452R (e.g., B.1.617.2). While both groups retained neutralization capacity against all variants, plasma from previously infected vaccinated individuals displayed overall better neutralization capacity when compared to plasma from uninfected individuals that also received two vaccine doses, pointing to vaccine boosters as a relevant future strategy to alleviate the impact of emerging variants on antibody neutralizing activity.Keywords
This publication has 37 references indexed in Scilit:
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportThe New England Journal of Medicine, 2020
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responsesNature, 2020
- Real-time public health communication of local SARS-CoV-2 genomic epidemiologyPLoS Biology, 2020
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Nature, 2020
- Convergent antibody responses to SARS-CoV-2 in convalescent individualsNature, 2020
- Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent IndividualsPublished by Cold Spring Harbor Laboratory ,2020
- A serological assay to detect SARS-CoV-2 seroconversion in humansNature Medicine, 2020
- An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVarGenome Biology, 2019
- Airway Memory CD4 + T Cells Mediate Protective Immunity against Emerging Respiratory CoronavirusesImmunity, 2016
- Fitting Linear Mixed-Effects Models Usinglme4Journal of Statistical Software, 2015